Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

It’s not uncommon for middle-aged men to experience a decrease in libido or sexual performance. For decades, men were told to ...

Navigate the complex world of nutrition with science-backed information to make informed choices for your health and wellness ...

More than 40% of American's are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...